Cargando…
Intracellular targeting with engineered proteins
If the isolation, production, and clinical use of insulin marked the inception of the age of biologics as therapeutics, the convergence of molecular biology and combinatorial engineering techniques marked its coming of age. The first wave of recombinant protein-based drugs in the 1980s demonstrated...
Autores principales: | Miersch, Shane, Sidhu, Sachdev S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984483/ https://www.ncbi.nlm.nih.gov/pubmed/27547383 http://dx.doi.org/10.12688/f1000research.8915.1 |
Ejemplares similares
-
Specific targeting of the deubiquitinase and E3 ligase families with engineered ubiquitin variants
por: Gorelik, Maryna, et al.
Publicado: (2016) -
Antigenic mapping reveals sites of vulnerability on α-HCoV spike protein
por: Xiang, Jiangchao, et al.
Publicado: (2022) -
Cell-based passive immunization for protection against SARS-CoV-2 infection
por: Sawula, Evan, et al.
Publicado: (2023) -
Development of Monoclonal Antibodies to Detect for SARS-CoV-2 Proteins
por: Mishra, Nawneet, et al.
Publicado: (2022) -
Monoclonal antibodies binding data for SARS-CoV-2 proteins
por: Mishra, Nawneet, et al.
Publicado: (2022)